Cuffaro, B.; Assohoun, A.L.W.; Boutillier, D.; Peucelle, V.; Desramaut, J.; Boudebbouze, S.; Croyal, M.; Waligora-Dupriet, A.-J.; Rhimi, M.; Grangette, C.;
et al. Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria. Microorganisms 2021, 9, 565.
https://doi.org/10.3390/microorganisms9030565
AMA Style
Cuffaro B, Assohoun ALW, Boutillier D, Peucelle V, Desramaut J, Boudebbouze S, Croyal M, Waligora-Dupriet A-J, Rhimi M, Grangette C,
et al. Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria. Microorganisms. 2021; 9(3):565.
https://doi.org/10.3390/microorganisms9030565
Chicago/Turabian Style
Cuffaro, Bernardo, Aka L. W. Assohoun, Denise Boutillier, Véronique Peucelle, Jérémy Desramaut, Samira Boudebbouze, Mikael Croyal, Anne-Judith Waligora-Dupriet, Moez Rhimi, Corinne Grangette,
and et al. 2021. "Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria" Microorganisms 9, no. 3: 565.
https://doi.org/10.3390/microorganisms9030565
APA Style
Cuffaro, B., Assohoun, A. L. W., Boutillier, D., Peucelle, V., Desramaut, J., Boudebbouze, S., Croyal, M., Waligora-Dupriet, A.-J., Rhimi, M., Grangette, C., & Maguin, E.
(2021). Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria. Microorganisms, 9(3), 565.
https://doi.org/10.3390/microorganisms9030565